The Precocious Puberty drugs in development market research report provides comprehensive information on the therapeutics under development for Precocious Puberty , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Precocious Puberty . Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Precocious Puberty and features dormant and discontinued products.
GlobalData tracks nine drugs in development for Precocious Puberty by six companies/universities/institutes. The top development phase for Precocious Puberty is phase iii with four drugs in that stage. The Precocious Puberty pipeline has nine drugs in development by companies and 0 by universities/ institutes. Some of the companies in the Precocious Puberty pipeline products market are: Foresee Pharmaceuticals, Debiopharm International and Livzon Pharmaceutical Group.
The key targets in the Precocious Puberty pipeline products market include Gonadotropin Releasing Hormone Receptor (GNRHR).
The key mechanisms of action in the Precocious Puberty pipeline product include Gonadotropin Releasing Hormone Receptor (GNRHR) Agonist with eight drugs in Phase III. The Precocious Puberty pipeline products include four routes of administration with the top ROA being Intramuscular and two key molecule types in the Precocious Puberty pipeline products market including Synthetic Peptide, and Small Molecule.
Precocious Puberty overview
Precocious puberty refers to the early onset of physical and hormonal signs of puberty in children, occurring before the typical age range. The usual age range for the onset of puberty is considered to be between 8 and 13 years in girls and between 9 and 14 years in boys. Precocious puberty occurs when these changes begin much earlier than the normal range. Dignosis inculdes the medical history, physical examination and blood tests to measure hormone levels.
For a complete picture of Precocious Puberty ‘s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
